Stroke is a multi-factorial polygenic disease and is a major cause of death and adult disability. Administration of bone marrow stem cells protects ischemic rat brain by facilitating recovery of neurological functions. But the molecular mechanism of stem cells action and their effect on gene expression is not well explored. In this study, we have transplanted 1 9 10 6 human bone marrow mesenchymal stem cells (hBMMSCs) in middle cerebral artery occluded (MCAo) adult male Wistar rats through intracarotid artery route at 24 h after surgery. Motor behavioral tests (rotarod and open field) were performed to assess the changes in motor functions at day 0 and day1, 4, 8 and 14. The expression of studied genes at mRNA and protein level was quantified by using Q-PCR and western blotting, respectively. Further, we have assessed the methylation pattern of promoter of these genes by using methylation-specific PCR. Data were analyzed statistically and correlated. A significant improvement in behavioral deficits was observed in stem cells treated group after 14th day post stroke. Significantly (p < 0.05) increased mRNA and protein levels of brain derived neurotrophic factor and ANP genes in hBMMSCs treated group along with decrease in methylation level at their promoter was observed. On the other hand, significantly decreased mRNA and protein level of TSP1 and WNK1 in hBMMSCs treated group was observed. In conclusion, hBMMSCs administration significantly improves the behavioral deficits by improving motor and locomotor coordination. The promoter of TSP1 and WNK1 genes was found to be hyper-methylated in hBMMSCs group resulting in their decreased expression while the promoter of ANP and brain derived neurotrophic factor was found to be hypo-methylated. This study might shed a light on how hBMMSCs affect the gene expression by modulating methylation status.
Stroke is a multi-factorial polygenic disease in which both environmental and genetic factors are involved, is a major cause of death and adult disability. Patho-physiologically, it is caused as a result of a reduction in blood flow resulting in loss or death of brain tissue along with the formation of edema. In stroke pathogenesis and recovery, epigenetic processes are involved via both molecular and cellular mechanisms (Qureshi and Mehler 2010) . Abnormal DNA methylation profiles have been linked with many disorders, including stroke, insulin resistance (Robertson 2005; Gluckman et al. 2009 ). Endres et al. (2001) have demonstrated that levels of DNA methylation in the brain were increased upon ischemic injury (Endres et al. 2001) .
Recently stem cells therapies have emerged as a promising treatment for stroke (Manley and Steinberg 2012) . Stem cells therapy has the potential which is essential for facilitating recovery of neurological functions (Dharmasaroja 2009 ). Mesenchymal stem cells (MSCs) have the capability to differentiate into other cells in the brain such as astrocytes, neurons, and endothelial cells (Zhao et al. 2002; WisletGendebien et al. 2004) . Various studies have reported that MSCs secrete growth factors which may directly or indirectly influence the epigenetic changes (Doeppner and Hermann 2010; Lim et al. 2011) . It is reported that transplantation of MSCs after ischemic onset can reduce infarction size and improve behavioral outcome in rodent stroke models as a result of their angiogenic and neuroprotective effects (WisletGendebien et al. 2004; Dharmasaroja 2009 ).
There are different genes which play an important role during and after ischemia or at different stages and pathways, either being helpful in recovery process or causing the severity of ischemia. Atrial natriuretic peptide (ANP) is a gene that regulates blood pressure (BP) and fluid homeostasis (De Paolis et al. 2007) . Binding sites for ANP have been found on astrocytes and brain endothelial cells (Naruse et al. 1991; Lin et al. 1999) . Previous studies have reported that increased ANP level was found in patients with acute ischemic stroke and it shows an inhibitory effect on water and sodium accumulation by acting directly on central nervous system (CNS) and thereby acting as a protective factor in ischemic stroke (Lin et al. 1999) . WNK lysinedeficient protein kinase 1 (WNK1) is found in cell bodies of dorsal root ganglion, developing nervous system and brain vasculature (Delaloy et al. 2006) . It is reported that increased expression of WNK1 might contribute to variation in BP and increased vulnerability to essential hypertension which is a risk factor for stroke (Newhouse et al. 2005; Marques et al. 2011) . It is shown that WNK1-deficient mice have low BP which highlights the functional importance of WNK1 in ion transport and BP regulation (Newhouse et al. 2009 ).
Potential therapeutic uses of brain derived neurotrophic factor (BDNF) were studied in various neurological disorders (Nagahara and Tuszynski 2011) and it is a leading factor in learning and memory (Ke et al. 2011) . Epileptogenic, ischemic, and traumatic insults to the brain induce marked changes in BDNF gene expression (Lindvall et al. 1994) . BDNF can induce changes in synaptic plasticity, neurotransmitter, and neuropeptide production and plays a crucial role during development in modulating neuronal structure, function, and survival (Desai et al. 1999; Schinder et al. 2000; Hartmann et al. 2001) . BDNF administration before and after ischemia results in significant reduction in infarct size and BDNF expression is regulated by promoter DNA methylation (Schtibitz et al. 1997; Zhao et al. 2000) . Thrombospondin-1 (TSP1) has the capacity to slow down the process of angiogenesis (Adams and Lawler 2004) . Clinical data have suggested that angiogenesis is beneficial to the functional recovery in ischemic stroke (Liauw et al. 2008; Zhou et al. 2010) .
Despite extensive research, treatment for limiting the neuronal injury after the stroke has proven to be elusive. In this study, we have selected four genes, out of which two genes (ANP and BDNF) have a prominent role in recovery after stroke while two genes (TSP1 and WNK1) which promotes the ischemic cascade. We have evaluated the expression status and promoter methylation pattern of these genes (ANP, TSP1, BDNF, and WNK1) before and after the administration of human bone marrow-derived mesenchymal stem cells (hBMMSCs). To the best of our knowledge, there is no other study which has reported the effects of hBMMSCs on these genes expression and promoter methylation pattern in stroke model of rats.
Materials and methods

Animals
Adult male Wistar rats (weight 250-300 gm; RRID: RGD_2312511) used in the study. Animals were obtained from the Central Animal Facility [All India Institute of Medical Sciences (AIIMS), New Delhi, India]. All rats housing, care, and experimental procedures were carried out according to the guidelines of the Institutional Animal Ethics Committee (Registration no. 746/IACE/ 13; AIIMS, New Delhi) for the care and use of laboratory animals. This study was not pre-registered. All rats were housed under a temperature controlled room (24 AE 2°C) with standard condition maintaining a 12 h light/dark cycle, humidity (60-70%) and had free access to food and water.
Study design and animal groups
We have estimated number of animals (rats) considering the findings of the previous studies (Dell and Holleran 2002) . To obtain 80% study power and significance level (a) of 5% the number (n) of animals calculated for each group was 8. Rats were randomly divided into three experimental groups using randomization table method (Fisher 1938 ) (i) The control group (sham surgery operated control group; n = 8): in this group only surgical stress was given to the rats; (ii) phosphate-buffered saline (PBS) group or MCAo + PBS group (n = 8): in this group MCAo model was made and only PBS (vehicle for stem cells) was administered via intra-carotid artery route at 24 h after surgery; (iii) hBMMSCs or MCAo + hBMMSCs group (n = 8): in this group MCAo model was made and hBMMSCs re-suspended in PBS was administered via intra-carotid artery route at 24 h after surgery (Fig. 1) . To ensure the experiments are unbiased, the following measures were taken. Group code and identity number was given immediately after procuring the rats from central animal facility, AIIMS and before performing any behavioral/experimental intervention. Group numbers were not disclosed till the data analysis was done. All rats were given unbiased post-surgery care. The rats which do not fit to the training criteria or having motor behavioral impairment were excluded from the study. In rotarod test during training session, the rats which failed to stay on rotarod apparatus for 1 min at a constant speed of 8 revolutions were excluded from the study (no. of rats excluded =5). Mortality during or after the MCAo surgery procedure also results in exclusion of rats (Total no. of rats excluded=25; n = 10 in PBS group and n = 15 in hBMMSCs group).
Surgical procedure of transient MCAo and sham surgery
Rats in PBS and hBMMSCs groups were subjected to right MCAo by using the 2-h transient intra-luminal filament occlusion model of cerebral ischemia, following the protocol as described previously (Koizumi et al. 1986; Longa et al. 1989; Courtes et al. 2011) . In brief, ratswere anesthetized with an intraperitoneal injection of chloral hydrate (350 mg/kg; Sigma-Aldrich). After exposing the right external carotid artery (ECA), a small incision was made to the ECA and 4-0 silicone rubber-coated reusable monofilament was inserted into the lumen of the right internal carotid artery (ICA). The filament (4-0 Silicon coated monofilament; Doccol) was inserted to a depth of 18-19 mm (beginning with the common carotid artery bifurcation) to block the origin of the right middle cerebral artery (MCA); after 2 h of MCAo thread was withdrawn to cause reperfusion. Throughout the surgery procedure, body temperature was maintained at 37 AE 0.5°C, using a thermistor-controlled heated blanket. Analgesic 0.03 mg/kg buprenorphine was given to all surgery rats. In control group, rats underwent the sham surgery in which ECA was exposed but 4-0 monofilament was not inserted. After recovery from anesthesia each animal underwent the same postoperative care as the stroke surgery animals and were allowed free access to food and water. In PBS and hBMMSCs group rats were died either during the surgery or within 4 h after the surgery as a result of excessive blood loss, cutting of vagus nerve and tissue rupture. We did not observe any mortality in control group. 2,3,5-triphenyltetrazolium chloride (TTC; Sigma-Aldrich) staining was done in a separate group of 6 sham surgery (control) and 6 MCAo rats, to confirm the cerebral infarction (Popp et al. 2009 ).
Culturing and administration of hBMMSCs Human bone marrow samples were taken after getting informed consent. hBMMSCs were isolated and cultured as described previously (Bhasin et al. 2011) at Stem Cell Facility, AIIMS, New Delhi. One million hBMMSCs (PKH26 labeled; Sigma: MINI26) were administered in the hBMMSCs group after MCAo through an intracarotid artery route at 24 h after surgery (Ishizaka et al. 2013; Toyoshima et al. 2015; Yavagal et al. 2014) .
Intra-arterial stem cells administration
Stroke animals were re-anesthetized as described earlier with an intraperitoneal injection of chloral hydrate (350 mg/kg, body weight) and sutures on the incision site were reopened to expose right common carotid artery (CCA), ICA and ECA. A 4-0 silk suture was used to uplift the right CCA and ECA and a loose loop was created on the artery. 31 gauge insulin syringe was inserted in the ECA and was used to administer one million stem cells suspended in 0.3 mL PBS in hBMMSCs group and 0.3 mL PBS in vehicle rat group. Cells were injected very slowly (100 lL/min) into ICA through the needle via ECA. The silk loop was used as a control to prevent blood flow. After completion of the injection the needle was held in the same position, for 45-60 s and the injection site was pressed, using sterilized gauge after removing the needle. The gauge was pressed down on the right CCA for a minimum of 5 min. The infusion needle was removed after transplantation, and the ECA stump was tighten. The incision was Fig. 1 A flow chart illustrating the experimental procedures employed in this study. Adult male Wistar rats were randomly divided into the three main groups i.e., control, Phosphate Buffer Saline (PBS) and human bone marrow mesenchymal stem cells (hBMMSCs) groups. Further, each group was subdivided according to the time period (8th and 14th day post surgery) and there were eight rats in each group. Rotarod and Open field tests were done at day 0 (baseline), 1, 4, 8 and 14 while QPCR, WB and MSP were done at only at day 8 and 14 post stroke. WB: Western Blotting; QPCR: Real time quantitative PCR; MSP: Methylation-specific PCR; n = number of rats.
sutured and animals were given 3 ml of warm normal saline (0.9%). All animals were given 0.3 mg/kg body weight buprenorphine subcutaneously once they were awake. (Ishizaka et al. 2013; Toyoshima et al. 2015; Shin et al. 2016) Assessment of behavioral deficit All studied rats underwent two behavioral tests, a rotarod and open field to assess the motor coordination and locomotor activity before surgery as a baseline (day 0) and at day 1, 4, 8, and 14 after surgery. Baseline readings at 24 h before surgery were the internal controls for each study animal. To ensure that all the rats are not starting their behavioral assessment with the same test, the sequence of tests (open field and rotarod) presentation was alternated. At day 1 rotarod test was performed first followed by open field test, at day 4 open field test was performed first followed by rotarod test, At day 8 rotarod test was performed first followed by open field test, and at day 14 open field test was performed first followed by rotarod test. Through this method it was ensured that the same test was not being done at the same pattern on first or last at any assessment day. All behavioral experiments were performed between 9 am to 2 pm.
For rotarod test, rats were placed on a motor driven rotating cylinder and duration of time rats remained on it before falling was recorded (Rogers et al. 1997) . Each animal received training session of 3 trials per day for 3 days before MCAo on the rotarod apparatus, at a constant speed of 8 rpm for 60 s. One day before surgery, the final reading of trained rats was taken on an accelerating cylinder increasing from 4 to 40 rpm over a period of 5 min, and latency time was recorded digitally. For the open field test, rats were individually placed in the center of the arena and were tracked with a video camera connected to the computer. The arena was cleaned after testing for each animal. The software Ethovision XT 5.1 by Noldus was used to record and analyze the data and animals were recorded for 10 min for every trial. Total distance moved (cms) by each animal during the 10 min trial was compared to assess the locomotor activity (Ouhaz et al. 2015) .
Tissue processing and immunohistochemistry 14 days after stroke, animals were transcardially perfused, and brains were extracted and sectioned at 20-lm post-fixation (Sanderson and Wider 2013) . Immuno-histochemistry was performed to co-localize the transplanted hBMMSCs (PKH26 labeled) with the neuronal marker (NeuN; RRID: AB_2298772). In brief, first slides were washed with PBS followed by three washing for 5 min with PBSTx. After washing slides were blocked with 10% Bovine serum albumin [(Sigma-Aldrich) made in PBS] for 2 h. Sections were incubated overnight at 4°C with NeuN primary antibody (Anti NeuN, RRID:AB_2298772; dilution 1 : 100) followed by three washing for 5 min with PBSTx and then incubated with Alexafluor 488 secondary antibody (goat anti-mouse IgG; RRID: AB_2534069; dilution 1 : 200) for 2 h at 25°C followed by mounting using Vectashield mounting media with 4 0 -6-Diamidino-2-phenylindole (DAPI) (Vector Laboratories Catlog# H-1200 RRID:AB_2336790) and sections were imaged using fluorescence microscope.
Brain tissue processing for molecular analysis Brain tissue was sectioned in the rat brain matrix (Stoelting: Steel Brain Matrix, 1.0 mm, Coronal, 175-300 g; Catlog # 51388) and 2 mm coronal sections were dissected from frontal pole. Sections between 2 and 8 mm (bregma 4.0 to À2.0 AE 0.5 mm, Paxinos and Watson 1998) which includes the main portion of the infarct and peri-infarct was used to study of expression of mRNA, protein and methylation status (Popp et al. 2009 ).
Quantitative mRNA expression by real-time reverse transcription PCR The mRNA levels of target genes (ANP, WNK1, BDNF, and TSP1) were analyzed through relative quantitation using ABI 7500 realtime PCR (Applied Biosystems Inc., Kenilworth, NJ, USA). Total RNA was isolated by ethanol-chloroform (Merck, Kenilworth, NJ, USA) precipitation from peripheral blood mononuclear cells (PBMCs) isolated from blood and homogenized brain tissue (right side of the brain having core infarct and infarct boundary zone which included parts of the cortex and striatum region) using TRIZOL reagent (AMRESCO; Catlog# N580). One microgram of the total RNA was used to prepare cDNA using OligodT (ThermoFisher Scientific, Grand Island, NY, USA; Catlog # S0132) that was used as template in real-time PCR. Twenty microliters of reaction mixture included the Maxima SYBR Green master mix (ThermoFisher Scientific; Catlog # K0221), cDNA, and the nuclease free water. Experiments were performed in triplicates. The conditions for PCR were initial denaturation at 95°C for 5 min, followed by 40 cycles at 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s. b-actin was used as the endogenous control for quantitation. The forward and reverse primers sequence used for PCR are as follows:-ANP:
Mean Ct values were calculated for each molecule using 2Àd Ct method, where Ct values of the molecules were normalized to that of b-actin.
Western blotting
PBMCs isolated from blood and homogenized brain tissue (right side of the brain having core infarct and infarct boundary zone which included parts of the cortex and striatum region) were lysed in RIPA lysis buffer containing protease inhibitor cocktail (Thermo-Fisher Scientific; Catlog # 78437) and EDTA (Thermo-Fisher Scientific; Catlog # R1021 
Results
Infarct assessment after MCAo by TTC staining
We have used filament stroke model in this study. Rats were subjected to 2 h right MCAo. We have found [Total no. of rats died (10)/Total no. of rats used (26) 9 100] = 38% mortality in PBS group (MCAo+ PBS) and [Total no. of rats died (15)/Total no. of rats used (31) 9 100] = 48% mortality in hBMMSCs group (MCAo + hBMMSCs), and all these rats were died either during surgery or within 4 h after the surgery as a result of excessive blood loss, cutting of vagus nerve and tissue rupture. We did not observe any mortality in control group. To standardized MCAo and confirm the reproducibility of the stroke model, infarct was assessed, using TTC staining. Twenty-four hours after MCAo, rats had a lesion in the right hemisphere as compared to control animals ( Fig. 2a) .
Co-localization of hBMMSCs with neuronal marker Administrated PKH26 labeled hBMMSCs have reached the site of injury or ischemic boundary zone in rat brain were visualized under fluorescence microscope (Fig. 2b(i) ) Transplanted hBMMSCs were co-localized with NeuN positive cells (Fig. 2b(ii) ) suggesting their probable differentiation into neurons in a peri-infarct zone at 14 days after transplantation ( Fig. 2b(iv) ). The negative controls (Fig. 2b(v) ) in which primary antibody was omitted and only the secondary antibody Alexafluor 488 goat anti-mouse IgG was used carried out simultaneously with the experimental samples.
hBMMSCs administration improves motor functional recovery after stroke Rotarod test was done to assess motor movement in all the studied groups up to the 14th day after surgery. There was no significant difference in the duration of stay on rotarod apparatus among the groups before MCAo (284.5 AE 14.8 s in group 1, 284.5 AE 24.9 s in group 2 and 283.3 AE 19.5 s in group 3). After the stroke at 24 h, latency to fall from the rotating rod was significantly more in group 2 and group 3 as compared to group 1 (p = 0.001). All stroke animals displayed a trend of improvement in motor coordination starting day four post-stroke but there was no significant difference in group 3 at day one and day four when compared with group 2 (p = 0.837). However, group 3 animals showed significant recovery in rotarod test at day 8 (p = 0.001) and day 14 (p = 0.0001) as compared to group 2 (Fig. 3a) .
Improvement in locomotor activity after hBMMSCs administration
Open field test was done to assess the locomotor activity in rats. There was no significant difference in baseline readings of open field test among the groups before MCAo (3670.6 AE 96.7 cm in group 1, 3741.3 AE 133 cm in group 2 and 3760.3 AE 92.6 cm in group 3). There was a decrease in locomotor activity after stroke in both group 2 and 3 at day one as compared to group 1 but it gets improved as the time progresses (i.e., at day 4 up to day 14). The locomotor activity improved significantly at day 8 (p = 0.0001) and day 14 (p = 0.0001) in group 3 as compared to group 2 (Fig. 3b) . Differential mRNA expression of studied genes and their modulation by hBMMSCs administration We have assessed the mRNA levels of studied genes (ANP, WNK1, BDNF, and TSP1) in the PBMCs and homogenized brain tissue (right side) in all groups. At day 8 and 14 after stroke, mRNA levels of all the studied genes were significantly (p < 0.05) higher in the brain tissue as well as in PBMCs in group 2 and 3 as compared to group 1. At day 8, we have observed insignificant increase at mRNA levels of ANP and BDNF in both brain tissue and PBMCs in group 3 as compared to group 2. However, a comparison of their mRNA levels at day 14, a significant increase was observed in group 3 as compared to group 2 in both brain tissue (p = 0.039) and PBMCs (p = 0.045). When we have compared the mRNA levels of WNK1 and TSP1 at day 8 and day 14 between group 2 and group 3, significant decrease was observed in group 3 as compared to group 2 only at day 14 in both brain tissue (p = 0.0215) and PBMCs (p = 0.0206) ( Fig. 4a and b) .
Expression of studied genes at protein level and their alteration by hBMMSCs administration
At day 8 and day 14 after stroke, protein levels of all the studied genes (ANP, WNK1, BDNF, and TSP1) was found to be significantly increased (p < 0.05) in both brain (right side) as well as in PBMCs in group 2 rats and group 3 rats as compared to group 1 rats. At day 8, we have observed insignificant increase at protein levels of ANP and BDNF in both brain tissue and PBMCs in group 3 as compared to group 2. However, a comparison of their protein levels at day 14, a significant increase was observed in group 3 as compared to group 2 in both brain tissue (p = 0.048) and PBMCs (p = 0.045). When we have compared the protein level of WNK1 and TSP1 at day 8 and 14 between group 2 and group 3, a significant decrease was observed in group 3 as compared to group 2, only at day 14 in both brain tissue (p = 0.035) and PBMCs (p = 0.045) (Figs 5 and 6 ).
Methylation status of promoter of studied genes and their modification by hBMMSCs administration
On the band intensity analysis of the product of MSP of genes ANP and BDNF in the brain (right side), we have analyzed that at day 8 and day 14, the methylation was significantly (p ≤ 0.05) less in group 3 as compared to group 2 and group 1. Methylation was less in group 2 as compared to group 1 but the decrease was insignificant. On the band intensity analysis of the MSP product of TSP1 and WNK1 genes, we have analyzed that at day 8, the methylation was significantly (p ≤ 0.05) more in group 3 as compared to group 2 but when compared to group 1, an increase was insignificant. We have also observed significantly (p ≤ 0.05) less methylation in group 2 as compared to group 1. On the band intensity analysis of day 14 MSP product, we have found that the methylation was significantly (p ≤ 0.05) more in group 3 as compared to group 2 and group 1. On comparison with group 1, group 2 showed significantly (p ≤ 0.05) less methylation (Fig. 7) .
Correlation analysis among mRNA levels, Protein levels, and Methylation status On correlation analysis, when the mRNA levels and promoter methylation pattern of ANP were correlated with that of BDNF, it showed a significant positive correlation whereas, on correlation with TSP1 (mRNA, protein levels, and promoter methylation pattern), it showed a significant negative correlation. ANP and WNK1 protein levels and promoter methylation pattern showed significant negative correlation. When the mRNA levels of BDNF were correlated with WNK1, it showed a significant negative correlation. Upon correlation of mRNA levels and promoter methylation pattern of TSP1 with WNK1, significant positive correlation was observed (Table 2) .
Discussion
There is no such treatment available for stroke which helps in recovery after ischemic insult. Tissue plasminogen activator has some beneficial effects but limited to a very narrow time window after stroke. MSCs have promising therapeutic potential which can be applied for the recovery from stroke as they secrete angiogenic, antiapoptotic factors, and have the ability to migrate to damaged tissue, differentiating into neuronal cells, and also improve motor functions (Jeong et al. 2014; vanVelthoven et al. 2014) . In this study, we have explored selected genes (ANP, TSP1, BDNF, and WNK1) and their expression at mRNA and protein level and correlate their expression with promoter methylation pattern and the behavioral tests before and after the therapeutic intervention of hBMMSCs. Various reports have shown that CXC-chemokine receptor-4 is expressed in MSCs which may contribute to the delivery of transplanted MSCs into injured brain. The microenvironment in which MSCs are delivered, the presence of inflammation, loss of trophic/ growth factors, and Akt signaling, may play a role in maintaining the proliferation, differentiation, and survival of MSCs population at the site of infarction. (Rodrigues et al. 2010; Xiong et al. 2010; vanVelthoven et al. 2014) . hBMMSCs group (group 3) showed significant improvement in motor and locomotor activity at day 8 and day 14 after surgery as compared to PBS group (group 2). Our results are in concordance with the study by Komatsu et al. (2010) . We have found that administered hBMMSCs showed co-localization with neuronal marker (NeuN) which suggests their probable differentiation into mature neuron within 14 days of transplantation which is in concordance with previous studies (Rodrigues et al. 2010; Xiong et al. 2010; Wei et al. 2012; vanVelthoven et al. 2014) . Neurons secrete BDNF to induce neuro-protection and it is also a major growth factor secreted by MSCs (Chen et al. 2013; Jeong et al. 2014; vanVelthoven et al. 2014) . In our study, we have found increased expression of BDNF at mRNA as well as at protein level in hBMMSCs group (group 3) as compared to PBS group (group 2) which might be the possible reason behind improved motor and locomotor activity because BDNF possibly promotes the synaptic and axonal plasticity associated with learning, memory, and sensorimotor recovery (Ploughman et al. 2009; Jeong et al. 2014; vanVelthoven et al. 2014; Niimi et al. 2016) . BDNF also has a role in neurogenesis and might have helped in the survival of remaining neurons in the hBMMSCs group (group 3) as compared to PBS group (group 2), which do not have BDNF secreted by hBMMSCs.
It is reported that structural alterations of ANP gene are associated with the increased risk of stroke in both rats and humans (Kim et al. 2012b) . ANP gene provides a protective effect against stroke via mediating vasorelaxation, diuresis, and natriuresis ability and binding sites of ANP has been found in areas involved in body fluid volume and blood pressure regulation (Lin et al.1999; Rubattu et al. 1999) . Lin et al. (1999) have reported that adenovirus-mediated continuous gene delivery of ANP into Dahl-salt sensitive rats helped in a reduction in the stroke-induced mortality rate (Lin et al. 1999) . In the hemorrhagic stroke, it was found that ANP decreased brain edema when administered 4 h after injury (Ibaragi et al. 1989; Rosenberg and Estrada 1995) . Administration of autologous bone marrow-derived mononuclear cells results in the up-regulation of ANP levels in patients with refractory chronic heart failure (Gao et al. 2006) . MSCs also secrete brain natriuretic peptide (a close homolog of the ANP) which significantly reduces the formation of post-ischemic edema (Song et al. 2004; Doeppner and Hermann 2010) . ANP stimulates the expression of tissue growth factor-beta mRNA and protein which ultimately induces changes in promoter methylation and expression of specific genes by altering expression and activity of DNA methyltransferase (Wolf et al. 1995; Cardenas et al. 2014) (Fig. 8) . Increased production of BDNF by transfected MSCs helped in promoting functional recovery and reducing infarct size in stroke rats (Kurozumi et al. 2004) . Importantly, it also has been seen that attenuating BDNF transcription at mRNA level prevented behavioral recovery and sensorimotor functions in BDNF heterozygous mice compared with wild-type mice (Nygren et al. 2006) . In a previous study, a role of DNA methylation in the regulation of BDNF expression was established in cultured rat neurons (Ikegame et al. 2013) . CpG methylation at promoter regions on the BDNF gene regulates BDNF release and influence sensory motor outcomes in stroke (Kim et al. 2012a) . Chen et al. (2015) in their study showed that over-expression of BDNF in poststroke rats alleviates depression-like behaviors . Liu et al. (2014) in their study reported that BDNF levels at mRNA and protein were significantly higher at day 14th post stroke after administration of adipose tissuederived MSCs . Our results are also in concordance with the previous studies (Fig. 8) .
In our study, we have found significant up-regulation of ANP and BDNF at both mRNA and protein level after stroke induction in both PBS (group 2) and hBMMSCs (group 3) groups compared to control group (group 1). The levels were further increased significantly at day 14 in both brain tissue and PBMCs in hBMMSCs treated group (group 3) as compared to PBS group (group 2). We have also observed the hypomethylation of ANP and BDNF promoter in hBMMSCs treated group (group 3) when compared to PBS group (group 2) at day 8 which might be the reason behind the increase in ANP and BDNF expression in hBMMSCs treated group (group 3). Methylation of ANP and BDNF promoter got further decreased at day 14 in hBMMSCs treated group (group 3) resulting in significant increase in ANP and BDNF expression in the brain as compared to PBS group (group 2).
Modest changes in BP increase the risk of stroke (Xiomara et al. 2012) .There are studies which showed an association between variants of WNK1 and essential hypertension (Newhouse et al. 2005; Tobin et al. 2008) . It was shown that WNK1-deficient mice have low BP which has highlighted the functional importance of WNK1 in BP regulation (Zambrowicz et al. 2003) . Recently Cai et al. (2014) have found that if there is a polymorphism in WNK1 gene then the risk of ischemic stroke decreased (Cai et al. 2014) . Epidermal growth factor receptor plays a role in the regulation of WNK1 (Xu et al. 2005) and its long-term activation stimulates numerous downstream signaling cascades which play a role in DNMT expression and DNA methylation (Sabrina et al. 2012) (Fig. 8) .
It is well known that ischemia induces angiogenesis, and the extent of angiogenesis has been correlated with survival in stroke patients. Over-expression of TSP-1 retards angiogenesis resulted in delayed healing after stroke (Hayashi et al. 2003; Lin et al. 2003; Liu et al. 2014) . It is reported that TSP-1, regulates the expression of Vascular endothelial growth factor (VEGF) via TSP1-CD36 signaling pathway (Lin et al. 2003; Xing et al. 2010) . Hu et al. (2006) reported that the TSP-1 promoter region is rich in CpG islands and hyper methylation in this region is associated with reduced expression of TSP-1 (Hu et al. 2006) . Stem cells secrete micro-RNAs (miRs) which are essential determinants of angiogenesis as well as contributors to stroke pathogenesis (Chen et al. 2010; Song et al. 2015; Yin et al. 2015) . Previous studies have reported the increased TSP-1 expression after intracerebral hemorrhage in rat brain. (Lin et al. 2003; Zhou et al. 2010; Yang et al. 2012; Dong et al. 2015) . Another study also showed the up-regulation of TSP-1 in BDNFMet/Met mice up to 7 day after ischemia (Hu et al. 2006; Qin et al. 2011) (Fig. 8) .
In this study, we have found significant up-regulation of WNK1 and TSP1 at both mRNA and protein level after stroke induction in both PBS (group 2) and hBMMSCs group (group 3) compared to control group (group 1). At day 14 after stroke, we have observed a significant decline of WNK1 and TSP1 in Fig. 8 Shows the role of various molecules (ANP, BDNF, TSP1, and WNK1) in the pathogenesis of stroke. WNK1 and TSP1 seem to be responsible for potentiating stroke etiology by inducing hypertension and reducing angiogenesis. On the other hand, ANP and BDNF attenuate the edema formation and neuronal loss thereby attenuating stroke-induced damage. Stem cell intervention results in downregulation of culprit genes and up-regulation of beneficial genes by modulating the methylation pattern of these genes. WNK1: WNK lysine-deficient protein kinase 1; TSP1: Thrombospondin-1; ANP: Atrial Natriuretic Peptide; BDNF: Brain derived neurotrophic factor; VEGF: Vascular endothelial growth factor; BNP; Brain natriuretic peptide. both brain tissue and PBMCs in hBMMSCs treated group (group 3) as compared to PBS group (group 2). We have also observed the hyper-methylation of WNK1 and TSP1 promoter in hBMMSCs treated group (group 3) when compared to PBS group (group 2) at day 8 which might be the reason behind the decrease in WNK1 and TSP1 expression in hBMMSCs treated group (group 3). MSCs also secrete growth factors such as VEGF (anti-TSP1) which might be one of the factors resulting in decreased TSP1 expression. Methylation of WNK1 and TSP1 promoter got further increased at day 14 in hBMMSCs treated group (group 3) resulting in significant decrease in WNK1 and TSP1 expression at day 14 in the brain as compared to PBS group (group 2).
Conclusions
Overall behavioral analysis showed that hBMMSCs were more effective in improving the motor or behavioral deficits caused by stroke. This improved recovery seen in the hBMMSCs administered group may attribute to their ability to induce endogenous BDNF. hBMMSCs administration significantly down-regulated the genes (WNK1 and TSP1) which are responsible for hypertension and angiostatic activity. It also results in significant up-regulation of the genes (ANP and BDNF) which are responsible for reducing edema, hypertension and promoting neovascularization. This study might shed a light on how hBMMSCs affect the gene expression either by altering the promoter methylation pattern of genes directly or by secreting the growth factors, micro RNAs and other factors which might ultimately affect the signaling involved. A further study is needed to explore the possible mechanism and exact signaling behind the beneficial effects of hBMMSCs administration in stroke (Fig. 8) .
